help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on December 23, 2003, doi:10.1164/rccm.200310-1448OC

Am. J. Respir. Crit. Care Med., Volume 169, Number 8, April 2004, 910-914

A more recent version of this article appeared on April 15, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200310-1448OCv1
169/8/910    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waterer, G. W
Right arrow Articles by Wunderink, R. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waterer, G. W
Right arrow Articles by Wunderink, R. G

Submitted on October 24, 2003
Accepted on December 22, 2003

Medium-term survival after hospitalization with community-acquired pneumonia

Grant W Waterer1*, Lori A Kessler2, and Richard G Wunderink2

1 Medicine, University of Western Australia, Perth, Australia, 2 Clinical Research, Methodist Le Boneheur Healthcare, Memphis, TN, USA

* To whom correspondence should be addressed. E-mail: waterer{at}cyllene.uwa.edu.au.

An episode of community-acquired pneumonia (CAP) has been suggested to predict greater than expected mortality after discharge from hospital. We ascertained the survival status as of December 2002 of a cohort of patients with CAP identified prospectively between November 1998 and June 2001. Cox-regression analysis was used to examine the impact of demographic factors, comorbid illnesses and CAP severity on subsequent mortality. Of 378 CAP survivors we ascertained the survival status of 366 (96.9%), 125 (34.1%) of whom had died. The mean length of follow up was 1058 days (range 602-1500). Independent predictors of mortality were increasing age (p<0.001), comorbid cerebrovascular (p=0.002) and cardiovascular (p=0.023) disease, an altered mental state (p<0.001), a hematocrit <35% (p=0.035) and increasing blood glucose level (p=0.025). In 41-80 year olds without significant comorbiditities there was a trend to greater than expected mortality. In conclusion, an episode of CAP in young adults without significant comorbid illnesses does not appear to be an adverse prognostic marker of medium-term survival. The trend to greater than expected mortality in patients over 40 years of age needs further study and physicians should be particularly alert for underlying life-limiting disease processes in patients presenting with acute confusion or a hematocrit<35%.


Key words: pneumonia, survival, long-term, hospitalization




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Yende, G. D'Angelo, J. A. Kellum, L. Weissfeld, J. Fine, R. D. Welch, L. Kong, M. Carter, D. C. Angus, and for the GenIMS Investigators
Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. Waterer, L. A. Kessler, and R. G. Wunderink
Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
Chest, July 1, 2006; 130(1): 11 - 15.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Rello, A. Rodriguez, A. Torres, J. Roig, J. Sole-Violan, J. Garnacho-Montero, M. V. de la Torre, J. M. Sirvent, M. Bodi, and for the CAPUCI study investigators
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Eur. Respir. J., June 1, 2006; 27(6): 1210 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Angus, A. Ishizaka, M. Matthay, F. Lemaire, W. MacNee, and E. Abraham
Critical Care in AJRCCM 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 537 - 544.
[Full Text] [PDF]


Home page
NEJMHome page
J. E. Heffner
Multicenter Trials of Treatment for Empyema -- After All These Years
N. Engl. J. Med., March 3, 2005; 352(9): 926 - 928.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. F. Dowell
Surviving Pneumonia--Just a Short-Term Lease on Life?
Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 895 - 896.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  ATS State of the Art 2009